Clinical Trial Finder

Search for recruiting clinical trials or get personalized matches based on your health profile.

Featured Trials

Recruiting studies in women's health. Sign in and complete your health profile for personalized matches.

RECRUITINGNA

Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding

A prospective, multi-center, noninferiority randomized controlled trial designed to compare the efficacy of UI-EWD (Nexpowder™) hemostatic powder versus conventional endoscopic hemostatic therapy in patients presenting with acute overt gastrointestinal bleeding which is found at endoscopy to be due to one of the following sources: a gastric or duodenal ulcer with active bleeding (spurting or oozing) or a non-bleeding visible vessel; an esophageal, gastric or duodenal tumor with active bleeding o

Sponsor: Medtronic - MITGEnrollment: 278Conditions: Acute Gastrointestinal Bleeding
Birmingham, Alabama, United States | New Haven, Connecticut, United States | Chicago, Illinois, United States +2 more
NCT06188585
RECRUITINGPHASE4

ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser Therapy

Vaginal atrophy patients receiving vaginal laser therapy will be treated with daily 7-0940® following a laser session to evaluate the safety and efficacy of the product as an adjunct treatment. Clinical outcomes will be assessed using validated investigator- and patient-reported measures, with safety and symptom progression monitored throughout the study.

Sponsor: Stratpharma AGEnrollment: 10Conditions: Vaginal Atrophy, Atrophic Vaginitis, Genitourinary Syndrome of Menopause (GSM)
Laguna Hills, California, United States
NCT07346287
RECRUITINGNA

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

In 2020, a cervical screening center was established in Zaporizhzhia (Ukraine), initiating a pilot project to evaluate the prevalence of HPV among women in Eastern Ukraine. The findings were intended to lay the groundwork for the Ukrainian Ministry of Health in establishing a structured national screening program. However, all efforts were halted due to the nearby armed conflict, situated just 40 kilometers from the border. The World Health Organization's goal to eliminate cervical cancer globa

Sponsor: Karolinska InstitutetEnrollment: 1000Conditions: Cervical Cancer, Cervical Cancer Screening, Human Papillomavirus (HPV) Infection
Zaporizhzhya, Ukraine
NCT07275333
RECRUITINGPHASE3

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be bette

Sponsor: SWOG Cancer Research NetworkEnrollment: 2400Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Birmingham, Alabama, United States | Anchorage, Alaska, United States | Anchorage, Alaska, United States +2 more
NCT05929768
RECRUITINGPHASE4

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

TIVDAK is used for the treatment of cervical cancer that has come back after chemotherapy. Chemotherapy is a treatment that uses medicines to stop the growth of cancer cells. This is done either by killing the cells or by stopping them from growing. The purpose of this study is to learn about possible side effects of TIVDAK, specially to any side effect that is related to the eye. A side effect is anything a medicine does to your body that is not part of how the medicine treats disease. * This

Sponsor: PfizerEnrollment: 100Conditions: Cervical Cancer
Phoenix, Arizona, United States | Phoenix, Arizona, United States | Phoenix, Arizona, United States +2 more
NCT06952660

We use cookies for authentication and to improve your experience. Learn more